Loading clinical trials...
Loading clinical trials...
Double-Blind, Randomized, Active-Controlled Comparison of the Immunogenicity and Safety of Flublok® Quadrivalent Versus IIV4 in Healthy, Medically Stable Adults 18-49 Years of Age
Conditions
Interventions
Flublok Quadrivalent
Inactivated Influenza Vaccine (IIV4)
Locations
10
United States
Benchmark Research - Sacramento
Sacramento, California, United States
Clinical Research of South Florida
Coral Gables, Florida, United States
Meridian Clinical Research
Savannah, Georgia, United States
Heartland Research Associates, LLC
Wichita, Kansas, United States
Benchmark Research
Metairie, Louisiana, United States
Meridian Research
Bellevue, Nebraska, United States
Start Date
October 1, 2014
Primary Completion Date
May 1, 2015
Completion Date
May 1, 2015
Last Updated
October 27, 2016
NCT07291635
NCT06094010
NCT06417762
NCT06160128
NCT07396428
NCT07310472
Lead Sponsor
Protein Sciences Corporation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions